Literature DB >> 9420249

Disease induction by virus derived from molecular clones of equine infectious anemia virus.

S L Payne1, X M Qi, H Shao, A Dwyer, F J Fuller.   

Abstract

Equine infectious anemia virus (EIAV), a macrophage-tropic lentivirus, causes persistent infections of horses. A number of biologic features, including the rapid development of acute disease, the episodic nature of chronic disease, the propensity for viral genetic variation, and the ability for many infected animals to eventually control virus replication, render EIAV a potentially useful model system for the testing of antiretroviral therapies and vaccine strategies. The utility of the EIAV system has been hampered by the lack of proviral clones that encode promptly pathogenic viral stocks. In this report, we describe the generation and characterization of two infectious molecular clones capable of causing acute clinical syndromes similar to those seen in natural infections. Virus derived from clone p19/wenv17 caused severe debilitating disease at 5 to 7 days postinfection; initial febrile episodes were fatal in two of three infected animals. Virus derived from a second clone, p19/wenv16, caused somewhat milder primary febrile episodes by 10 to 12 days postinfection in two of two infected animals. Virus derived from both clones caused persistent infections such that some animals exhibited chronic equine infectious anemia, characterized by multiple disease episodes. The two virulent clones differ in envelope and rev sequences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420249      PMCID: PMC109398     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Equine infectious anemia: current knowledge.

Authors:  C J Issel; L Coggins
Journal:  J Am Vet Med Assoc       Date:  1979-04-01       Impact factor: 1.936

2.  Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

Authors:  S L Payne; F D Fang; C P Liu; B R Dhruva; P Rwambo; C J Issel; R C Montelaro
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

3.  Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.

Authors:  K A Hussain; C J Issel; K L Schnorr; P M Rwambo; R C Montelaro
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay.

Authors:  J P Gregersen; H Wege; L Preiss; K D Jentsch
Journal:  J Virol Methods       Date:  1988-02       Impact factor: 2.014

5.  Study of the one-step growth curve of equine infectious anemia virus by immunofluorescence.

Authors:  C Ushimi; J B Henson; J R Gorham
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

6.  Immunofluorescent localization of equine infectious anemia virus in tissue.

Authors:  T C McGuire; T B Crawford; J B Henson
Journal:  Am J Pathol       Date:  1971-02       Impact factor: 4.307

7.  Growth characteristics of equine infectious anemia virus in horse leukocyte cultures. Brief report.

Authors:  Y Kono; T Yoshino; Y Fukanaga
Journal:  Arch Gesamte Virusforsch       Date:  1970

8.  Propagation and titration of equine infectious anemia virus in horse leukocyte culture.

Authors:  K Kobayashi; Y Kono
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1967

9.  Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.

Authors:  R C Montelaro; B Parekh; A Orrego; C J Issel
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

10.  Characterization of equine infectious anemia virus long terminal repeat.

Authors:  D Derse; P L Dorn; L Levy; R M Stephens; N R Rice; J W Casey
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

View more
  6 in total

1.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.

Authors:  Katia Cappelli; Stefano Capomaccio; Frank R Cook; Michela Felicetti; Maria Luisa Marenzoni; Giacomo Coppola; Andrea Verini-Supplizi; Mauro Coletti; Fabrizio Passamonti
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

3.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

4.  Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.

Authors:  Diana T Cervantes; Judith M Ball; John Edwards; Susan Payne
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

5.  Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Authors:  Isabel Fidalgo-Carvalho; Jodi K Craigo; Shannon Barnes; Carolina Costa-Ramos; Ronald C Montelaro
Journal:  Vet Microbiol       Date:  2008-11-01       Impact factor: 3.293

6.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.